🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures

RecruitingNAAges 65 Years - 120 YearsAllHelse Stavanger HF
NCT04868305 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A hip fracture is a large burden to the patient with increased mortality, pain and increased need for daily assistance. Trochanteric fractures of the femur (FTF) represents about 35% of the hip fractures. Today FTFs are mainly treated with internal fixation using sliding hips screws (SHS) or intramedullary nail (IMN), whilst hip arthroplasty (THA/HA) is rarely used. Despite advances in the design of the internal fixation implants there is a high failure rate, in particular in cases of FTFs classified as unstable fractures. Since the introduction of hip arthroplasty in femoral neck fractures there has been a reduction in complication rates, early mobilization and shorter hospital stays. The primary objective of this project is to investigate if treatment with hip arthroplasty in unstable FTFs will increase the postoperative mobility, give a better general health outcome for the patient,

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 65 years * American Society of Anesthesiology Score (ASA) \< 4 * Ambulant with or without aid (preinjury) * Radiological verified unstable trochanteric hip fracture (AO 31A2.2 - 3.3) * Written consent obtained by patient or his/her next of kin Exclusion Criteria: * Previous hip surgery on ipsilateral or contralateral side * Non-ambulant preinjury * Patient not living in the area of hospital care
💊

What it tests

  • Intramedullary nail
  • Hip arthroplasty
📍

Where

1 site
Stavanger University Hospital
Stavanger, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy